Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HC9 Ventures is a venture capital firm based in the United States, dedicated to supporting the growth of healthcare technology and services companies. The firm focuses on Seed and Series A investments, partnering with founders to scale emerging healthcare businesses through capital and industry expertise.
HC9 Ventures primarily invests in Seed and Series A stages, recognizing the potential for significant returns at these early phases. The firm emphasizes healthcare technology and services, aiming to improve access, convenience, and costs in healthcare delivery. They collaborate closely with Limited Partners and industry leaders to guide their portfolio companies.
Notable portfolio companies include Alacura, which enhances medical transport services; Reema Health, focusing on underserved populations; XP Health, providing affordable vision care; Circadian Health, developing value-based specialty care solutions; and Forge Health, a comprehensive provider of mental health and substance use care.
Submit your pitch through their website's contact form for consideration.
As of Q4 2025, HC9 Ventures published a quarterly round-up highlighting ongoing activities and portfolio developments, and conducted an interview with Optura to showcase their engagement with industry players.
Yes, HC9 Ventures often leads investment rounds, particularly in Seed and Series A stages, to provide substantial support to their portfolio companies.
HC9 Ventures is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their healthcare focus.
Specific details regarding the fund size or assets under management are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.